Intratumor Cisplatin Nephrotoxicity in Combined Laser-Induced Thermal Therapy for Cancer Treatment
dc.citation.issue | 8 | |
dc.citation.volume | 49 | |
dc.contributor.author | Palumbo, Marcel N. [UNIFESP] | |
dc.contributor.author | Cervantes, Onivaldo [UNIFESP] | |
dc.contributor.author | Eugenio, Cecilia [UNIFESP] | |
dc.contributor.author | Hortense, Flavia T. P. [UNIFESP] | |
dc.contributor.author | Ribeiro, Joao C. [UNIFESP] | |
dc.contributor.author | Paolini, Ana Amelia P. | |
dc.contributor.author | Tedesco, Antonio C. | |
dc.contributor.author | Sercarz, Joel A. | |
dc.contributor.author | Paiva, Marcos B. [UNIFESP] | |
dc.coverage | Hoboken | |
dc.date.accessioned | 2020-08-04T13:40:09Z | |
dc.date.available | 2020-08-04T13:40:09Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Introduction: Thermal ablation of tumors by Nd:YAG laser has been growing as a multidisciplinary subspecialty defined as laser-induced thermal therapy (LITT), and has been increasingly accepted as a minimally invasive method for palliation of advanced or recurrent cancer. Previous studies have shown that adjuvant chemotherapy can potentiate laser thermal ablation of tumors leading to improved palliation in advanced cancer patients. Objective: Evaluate nephrotoxicity by early markers of renal function in treating head and neck cancer using intra-tumor injections of cisplatin combined with laser-induced thermal therapy CDDP-LITT). Methods: Nine patients with recurrent head and neck tumors were treated by CDDP-LITT in order to determine nephrotoxicity related to this synergistic association. Among the tests requested to detect early were creatinine, magnesium, creatinine clearance, serum urea-BUN, type I urine, and proteinuria at 24 hours. Results: Twelve recurrent tumors in nine patients were treated by CDDP-LITT. Pain was the major complaint four patients), while other symptoms included dysphagia, dyspnea, bleeding, and difficulties in chewing. Fifteen laser procedures were performed and maximal CDDP dose was 50mg. None of the markers for nephrotoxicity showed changes at these levels of CDDP intra-tumor injections. Conclusion: This initial experience with (CDDP-LITT) indicates both safety and therapeutic potential for palliation of advanced head and neck cancer. However, safety and feasibility must be confirmed by longer follow up and further escalation of CDDP doses in a Phase I study to determine maximum tolerated dose (MTD) and demonstrate tangible benefits for patients. (C) 2017 Wiley Periodicals, Inc. | en |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Otolaryngol & Head & Neck Surg, Sao Paulo, Brazil | |
dc.description.affiliation | Los Angeles Sinus & Allergy Inst, Los Angeles, CA USA | |
dc.description.affiliation | Univ Sao Paulo, Fac Philosophy Sci & Letters, Dept Chem, Lab Photobiol & Photomed, Sao Paulo, Brazil|Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Otolaryngol & Head & Neck Surg, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Department of Head and Neck Surgery, the Jonsson Comprehensive Cancer Center | |
dc.description.sponsorship | David Geffen School of Medicine at UCLA | |
dc.description.sponsorship | National Institute of Health, National Cancer Institute | |
dc.description.sponsorship | Office of Extramural Research, National Institutes of Health | |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) | |
dc.description.sponsorshipID | FAPESP: 08-54714 | |
dc.format.extent | 756-762 | |
dc.identifier | http://dx.doi.org/10.1002/lsm.22685 | |
dc.identifier.citation | Lasers In Surgery And Medicine. Hoboken, v. 49, n. 8, p. 756-762, 2017. | |
dc.identifier.doi | 10.1002/lsm.22685 | |
dc.identifier.issn | 0196-8092 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/57325 | |
dc.identifier.wos | WOS:000411028000004 | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Lasers In Surgery And Medicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | cisplatin | en |
dc.subject | laser-induced thermal therapy | en |
dc.subject | recurrent/advanced head and neck cancer | en |
dc.subject | Nd:YAG laser | en |
dc.subject | nephrotoxicity | en |
dc.title | Intratumor Cisplatin Nephrotoxicity in Combined Laser-Induced Thermal Therapy for Cancer Treatment | en |
dc.type | info:eu-repo/semantics/article |